Malaria prevention, without false certainty
Vaccines now protect millions of children. Travellers still need a different plan: know the destination, prevent bites, choose the right tablets and never ignore a fever.
282 millionestimated cases in 2024
610,000estimated deaths in 2024
WHO estimates. About 95% of deaths occurred in the African Region.Yes, vaccines exist
WHO recommends RTS,S and R21 for children living in areas where P. falciparum malaria is a public-health risk. They are not currently routine vaccines for adult travellers.
GSK · pre-erythrocytic vaccine
University of Oxford / Serum Institute of India
Young children in high-transmission African settings carry the greatest burden of severe disease and death. Limited global supply has therefore been directed where each dose prevents the most harm.
The vaccines passed laboratory and animal work, then phased human trials with ethical review and consent. Large studies were conducted in the children meant to benefit because immune response and real exposure cannot be established in animals alone. Scrutiny, transparency and fair access remain essential.
Current evidence, approvals, schedules and purchasing systems are designed mainly for childhood programs. Adult and traveller candidates, including whole-sporozoite vaccines and long-acting antibodies, are still being studied. There is no dependable general-release date.
Who pays? National governments and families are supported by Gavi, WHO, UNICEF and partners. The Global Fund and Unitaid helped fund pilots and wider malaria control; PATH and the Gates Foundation supported development. Funding and procurement are complicated, and broader aid cuts can weaken delivery systems even when a vaccine exists.
Five important human parasites
Species affects urgency, relapse risk, geography and treatment. Mixed infections occur, and microscopy can misidentify species.
Most prevalent in Africa and the deadliest species. Infected red cells can obstruct small vessels, including in the brain. Untreated disease may progress to severe malaria and death within 24 hours.
Cerebral malaria · severe anaemia · kidney/lung failureDominant in much of the world outside sub-Saharan Africa. Dormant liver forms can reactivate months or years later. It can be severe or fatal, despite an outdated reputation for being “benign.”
Needs blood-stage treatment plus radical cure after G6PD testingTwo closely related species, mainly in Africa and the western Pacific. Usually lower parasite density, but dormant liver forms cause relapses and severe illness is possible.
Also needs anti-relapse treatment after G6PD testingMay remain at low levels for years or decades without dormant liver forms. Classically causes a 72-hour fever cycle and has an association with chronic kidney disease and nephrotic syndrome.
No hypnozoites, but long persistence mattersA macaque parasite in parts of Southeast Asia, transmitted by forest-associated mosquitoes. Its roughly 24-hour replication cycle can produce rapid severe disease and it may be mistaken for other species on a blood film.
Treat urgently; severe disease and death can occurCan malaria be cured?
Uncomplicated malaria is usually curable with species- and location-appropriate antimalarials. Severe malaria requires hospital care and intravenous artesunate. P. vivax and P. ovale also need treatment of dormant liver stages, usually primaquine or tafenoquine after quantitative G6PD testing. Unknown species is managed as potentially dangerous falciparum malaria until clarified.
Consultation-preparation tool
This does not prescribe tablets or declare any destination safe. It organises the details that change professional advice.
Convenient for short trips; headache or stomach upset can occur. Avoid in severe renal impairment. Pregnancy advice is specialist territory. Often more expensive.
Often inexpensive and broadly effective. Sun sensitivity, nausea, thrush and oesophageal injury matter. Take with water and stay upright. Not generally used in pregnancy or children under 8.
Useful for long trips and some pregnancies, but unsuitable with important psychiatric illness, seizures or some cardiac-conduction problems. Trial before departure.
Only useful where parasites remain chloroquine-sensitive. It may worsen psoriasis and is not a substitute in resistant areas.
Especially useful where P. vivax predominates. Quantitative G6PD testing is mandatory. Not used in pregnancy; breastfeeding requires infant G6PD review.
Adult-only single-agent option in some countries. Requires quantitative G6PD testing; avoid in pregnancy and use caution with psychiatric history.
Doxycycline, Doxy-PEP and HIV PrEP
Doxycycline is useful, but “fairly harmless” is not the same as harmless, and malaria dosing should not be improvised into an STI regimen.
Usually taken as 100 mg every day during exposure and for four weeks afterward. It may reduce some doxycycline-sensitive bacterial infections, but it is not reliable protection against every STI and is not a complete sexual-health plan.
CDC guidance supports clinician-prescribed 200 mg within 72 hours after sex, no more than 200 mg in 24 hours, for selected gay and bisexual men and transgender women at higher bacterial-STI risk. Anyone anticipating new or multiple partners can ask for individual advice, but evidence is currently insufficient for a blanket recommendation in many other groups. Australian guidance is more cautious, especially because gonorrhoea resistance is common.
HIV PrEP is separate medication taken before ongoing exposure. HIV PEP is an emergency 28-day course started within 72 hours after a possible exposure. Doxy-PEP does not prevent HIV; HIV PrEP does not prevent syphilis, gonorrhoea or chlamydia.
Do not double-dose. If travel doxycycline, HIV PrEP/PEP or doxy-PEP may overlap, ask one clinician or pharmacist to coordinate the plan. Antibiotic resistance, side effects, interactions, STI testing, hepatitis/mpox/HPV vaccination and condoms still matter.
Layered prevention
Anopheles mosquitoes generally bite from dusk to dawn. No vaccine or medicine is 100% protective.
Use DEET, picaridin or another locally recommended repellent as directed.
Wear long, loose clothing after dusk; use permethrin-treated clothes and gear where appropriate.
Choose screened or air-conditioned rooms and use an insecticide-treated bed net correctly.
Start early enough, continue throughout exposure and complete the after-travel period.
Long-lasting insecticidal nets, indoor residual spraying, rapid testing and ACT treatment, seasonal chemoprevention, pregnancy prevention programs, surveillance and environmental management all reduce disease.
Chloroquine resistance transformed prophylaxis and treatment. Partial artemisinin resistance is now documented or suspected in several African countries as well as the Greater Mekong region. Combination therapy, quality medicines, adherence and surveillance protect remaining options.
Researchers are testing attractive toxic sugar baits, spatial repellents, sterile or incompatible males, gene-drive mosquitoes, parasite-blocking genetic approaches, transmission-blocking vaccines, monoclonal antibodies and improved drugs. Some are promising; none replaces today’s basics yet.
Diagnosis and prognosis
Fever, chills, headache, sweating, muscle aches, nausea and fatigue overlap with dengue, influenza, COVID-19 and many other infections.
Urgent microscopy and rapid diagnostic tests are the main first tests. A single negative result does not always exclude malaria early in illness or at low parasite density. Clinicians may repeat blood films 2–3 times over 24–48 hours when suspicion remains.
Confusion, unusual sleepiness, seizures, breathing difficulty, jaundice, dark urine, shock, abnormal bleeding, severe weakness, low blood sugar or reduced urine need emergency care. Cerebral malaria means impaired consciousness from severe malaria, usually P. falciparum.
Promptly treated uncomplicated malaria is usually cured. Risk rises with treatment delay, falciparum or knowlesi, pregnancy, young age, older age, no previous immunity, HIV, asplenia and major chronic illness. Survivors of cerebral malaria can have neurological after-effects.
Rarely. An already-infectious mosquito can arrive by aircraft or luggage (“airport malaria”). Local transmission can also occur if a competent local Anopheles mosquito bites a person carrying parasites, the parasite develops inside the mosquito over days, and that mosquito later bites someone else. It is not an immediate person-to-person relay on the same flight.
Transfusion, shared needles, transplant and congenital transmission are other uncommon routes. Ordinary household contact does not spread malaria. Imported cases in Bangkok, London or another city do not automatically mean sustained local transmission, but no place has literally zero risk.
Check live guidance
Country recommendations and medicine availability change. Use these links, then confirm your exact itinerary with a clinician.